Baltimore Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Baltimore Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$301K	Buy	+1,100	New	+$274K	0.49%	59
2018 Q3	$268K	Sell	1,100 -100	-8%	-$23K	0.43%	61
2018 Q2	$249K	Hold	1,200	–	–	0.37%	65
2018 Q1	$248K	Hold	1,200	–	–	0.37%	64
2017 Q4	$228K	Hold	1,200	–	–	0.32%	67
2017 Q3	$227K	Hold	1,200	–	–	0.32%	65
2017 Q2	$209K	Buy	+1,200	New	+$202K	0.3%	65

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Baltimore Capital Management's TMO Position: Q1 2019 in Review

Baltimore Capital Management opened a new position in Thermo Fisher Scientific (TMO) in Q1 2019: 1,100 shares worth $301K. The stake represents 0.49% of the portfolio and ranks #59 among its holdings. This is a return to the name: Baltimore Capital Management previously reported a position in TMO as recently as Q3 2018.

Baltimore Capital Management first reported a position in TMO in Q2 2017 and has held it in 7 quarters since. 1,522 funds tracked by Wall St. Rank hold TMO as of Q1 2019.

Baltimore Capital Management held 1,100 shares of Thermo Fisher Scientific worth $301K as of Q1 2019.
Thermo Fisher Scientific was a new Baltimore Capital Management position in Q1 2019.
Thermo Fisher Scientific made up 0.49% of Baltimore Capital Management's portfolio in Q1 2019, its #59 holding.
Baltimore Capital Management first reported a position in Thermo Fisher Scientific in Q2 2017 and has held it in 7 quarters since.
1,522 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2019.

Based on Baltimore Capital Management's 13F filing for Q1 2019, filed 14 May 2019.